Pelabresib and Rituxan combination showed significant clinical benefits in JAK inhibitor-naive myelofibrosis patients, achieving a 65.9% spleen volume reduction at 24 weeks. The MANIFEST-2 trial ...

The cost of Rituxan with and without insurance can depend on several factors, including your treatment plan. Drug savings programs can also lower the price you’ll pay for Rituxan. Rituxan ...

This, the third PML case to emerge, is prompting concerns because the affected patient is the first to contract the condition on Rituxan without any prior treatment with another immune suppressant.

Cancers must express the biomarker CD20 to allow Rituxan to bind. The FDA rejected CT-P10 earlier this year, citing poor aseptic techniques during filling of batches and other issues at Celltrion ...

The FDA has just approved its eleventh indication for BTK inhibitor Imbruvica (ibrutinib), making it an option with Roche’s Rituxan (rituximab) for newly-diagnosed patients aged 70 or below with ...

Excitement is building around bakuchiol salicylate – or bakusylan – a new molecule that boosts the performance of bakuchiol in skin care formulations. The bakuchiol trend is poised to evolve.

Cytokines regulate inflammation, autoimmunity and articular destruction in the joints of patients with rheumatoid arthritis. In particular, tumour-necrosis factor (TNF) has proved to be of ...

These are applied over painful joints and have fewer side effects than oral pain relievers. A few topical RA treatment options include salicylates, NSAIDs, lidocaine, menthol/camphor, capsaicin, and ...

Sales of Rituxan/MabThera declined 13% to CHF 1.38 billion due to biosimilar erosion. Sales of Avastin, approved for multiple oncology indications, were down 17% to CHF 1.2 billion due to ...

The C3 inhibitor was given pre- and post-RP-A501 treatment in combination with the enhanced prophylactic immunosuppressive regimen of sirolimus, rituximab (marketed as Rituxan® by Genentech ...

Under the new executive order:: $2,900 (Netherlands), a reduction of 55 percent. Rituxan. Cost per dose: $5,200 to $8,000. Used to treat non-Hodgkin's lymphoma. Under the new executive order:: $ ...